Risk of elective major noncardiac surgery after coronary stent insertion: a population-based study

Duminda N Wijeysundera1, Harindra C Wijeysundera, Lingsong Yun

  • 1Li Ka Shing Knowledge Institute of St. Michael's Hospital, 30 Bond Street, Toronto, Ontario, M5B 1W8, Canada. d.wijeysundera@utoronto.ca

Circulation
|August 16, 2012
PubMed

Insights

Elective surgery should be delayed 46-180 days after bare-metal stent implantation and over 180 days after drug-eluting stent implantation to minimize cardiac events.

Area of Science:

  • Cardiology
  • Cardiovascular Surgery
  • Health Services Research

Background:

  • Current guidelines recommend delaying noncardiac surgery until 30-45 days post-bare-metal stent (BMS) and 1 year post-drug-eluting stent (DES).
  • Optimal timing for noncardiac surgery after coronary stent implantation remains a critical clinical question.

Purpose of the Study:

  • To determine the optimal timing for major elective noncardiac surgery after coronary stent implantation.
  • To evaluate the association between the timing of surgery and major adverse cardiac events (MACE).

Main Methods:

  • A cohort study of 8116 patients (≥40 years) undergoing major elective noncardiac surgery in Ontario, Canada (2003-2009) after coronary stent implantation.
  • Linked registry and administrative health care data were used to track 30-day MACE (mortality, acute coronary syndrome, repeat revascularization).
  • A comparison cohort of 341,350 surgical patients without prior coronary revascularization was included.

Main Results:

  • The overall 30-day MACE rate in patients with coronary stents was 2.1%.
  • Event rates were highest when surgery occurred <45 days post-stent (BMS: 6.7%, DES: 20.0%).
  • For BMS, event rates decreased to 2.6% at 45-180 days and approached nonrevascularized individuals' rates after 180 days.
  • For DES, event rates were 1.2% after 180 days, similar to the nonrevascularized group.

Conclusions:

  • The earliest optimal interval for elective surgery is 46 to 180 days after BMS implantation.
  • For DES, surgery should be delayed for more than 180 days to achieve similar safety profiles.
  • These findings refine current recommendations for perioperative management of patients with coronary stents.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...